CoChat

Short-term Low-Dose mTORC1 Inhibition in Aged Rats Counter-Regulates Age-Related Gene Changes and Blocks Age-Related Kidney Pathology

Open access

The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Rapalogs, inhibitors of mTORC1 (mammalian target of rapamycin complex 1), increase life span and delay age-related phenotypes in many species. However, the molecular mechanisms have not been fully elucidated. We determined gene expression changes comparing 6- and 24-month-old rats in the kidney, liver, and skeletal muscle, and asked which of these changes were counter-regulated by a clinically-translatable (short-term and low-concentration) treatment, with a rapalog (RAD001). Surprisingly, RAD001 had a more pronounced effect on the kidney under this regimen in comparison to the liver or skeletal muscle. Histologic evaluation of kidneys revealed that the severity of chronic progressive nephropathy lesions was lower in kidneys from 24-month-old rats treated with RAD001 compared with vehicle. In addition to other gene expression changes, c-Myc, which has been shown to regulate aging, was induced by aging in the kidney and counter-regulated by RAD001. RAD001 caused a decrease in c-Myc protein, which could be rescued by a proteasome inhibitor. These findings point to settings for use of mTORC1 inhibitors to treat age-related disorders, and highlight c-Myc regulation as one of the potential mechanisms by which mTORC1 inhibition is perturbing age-related phenotypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/gerona/glx249

Cites

33 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Genes up- and down-regulated by aging from 6 months to 24 months in rat kidney, liver, and gastrocnemius muscle, and the impact of RAD001 on the expression of these age-perturbed genes at 24 months. Rats aged 4.5 month and 22.5 months were treated with vehicle and rats aged 22.5 months were treated with RAD001 for 6 weeks, with a read-out at 6 and 24 months. Transcriptional profiling in the kidney, liver and gastrocnemius muscle was carried out by RNA-seq. Heat maps (A, B, C) depict genes that are differentially expressed between 6- and 24 month-old tissues (p < .05 adjusted for false discovery rate [FDR]) and the impact of RAD001 on the expression profile of these age-regulated genes. The blue hash (#) indicates genes that are significantly different between 6- and 24-month-old vehicle treated rats (p < .05 adjusted for FDR) and the red asterisk (*) indicates genes that are significantly different between 24-month-old vehicle treated and 24-month-old RAD001 treated rats (p < .05 adjusted for FDR). Standardized expression levels, from low to high, are colored from green to red: thus gene up-regulation is shown by a transition from green to red, and down regulation by a transition from red to green. In each heat map image, each column represents a single rat and each row represents a single gene. N = 8–10 rats per group.
Figure 1. Genes up- and down-regulated by aging from 6 months to 24 months in rat kidney, liver, and gastrocnemius muscle, and the impact of RAD001 on the expression of these age-perturbed genes at 24 months. Rats aged 4.5 month and 22.5 months were treated with vehicle and rats aged 22.5 months were treated with RAD001 for 6 weeks, with a read-out at 6 and 24 months. Transcriptional profiling in the kidney, liver and gastrocnemius muscle was carried out by RNA-seq. Heat maps (A, B, C) depict genes that are differentially expressed between 6- and 24 month-old tissues (p < .05 adjusted for false discovery rate [FDR]) and the impact of RAD001 on the expression profile of these age-regulated genes. The blue hash (#) indicates genes that are significantly different between 6- and 24-month-old vehicle treated rats (p < .05 adjusted for FDR) and the red asterisk (*) indicates genes that are significantly different between 24-month-old vehicle treated and 24-month-old RAD001 treated rats (p < .05 adjusted for FDR). Standardized expression levels, from low to high, are colored from green to red: thus gene up-regulation is shown by a transition from green to red, and down regulation by a transition from red to green. In each heat map image, each column represents a single rat and each row represents a single gene. N = 8–10 rats per group.CC BY-NC-ND · PubMed Central
Figure 2. Functional annotation of gene pathways differentially regulated by age (6-months vs 24-months vehicle-treated groups) and by RAD001 (24-month vehicle vs 24-month RAD001-treated groups) in kidney, liver, and gastrocnemius (gastroc) muscle of rats. Boxes with a color transition from green to blue represent up-regulated pathways (AGE-UP or RAD-UP) with p < 10–20 (green) – p < 10–3 (blue). Boxes with a color transition from red to yellow represent down-regulated pathways (AGE-DW or RAD-DW) with p < 10–20 (red) – p < 10–3 (yellow). Numbers of genes that are regulated in either direction by age or RAD001 are indicated in brackets: eg, AGE-UP_Kidney (2641).
Figure 2. Functional annotation of gene pathways differentially regulated by age (6-months vs 24-months vehicle-treated groups) and by RAD001 (24-month vehicle vs 24-month RAD001-treated groups) in kidney, liver, and gastrocnemius (gastroc) muscle of rats. Boxes with a color transition from green to blue represent up-regulated pathways (AGE-UP or RAD-UP) with p < 10–20 (green) – p < 10–3 (blue). Boxes with a color transition from red to yellow represent down-regulated pathways (AGE-DW or RAD-DW) with p < 10–20 (red) – p < 10–3 (yellow). Numbers of genes that are regulated in either direction by age or RAD001 are indicated in brackets: eg, AGE-UP_Kidney (2641).CC BY-NC-ND · PubMed Central
Figure 3. Validation of interferon gamma (A) and (B) epithelial to mesenchymal transition pathways in the rat kidney. mRNA amounts of the selected genes were quantified by real-time quantitative polymerase chain reaction in the kidneys from 6-month-old rats treated with vehicle and 24-month-old rats treated with vehicle or RAD001. mRNA amounts of the genes of interest were normalized to a geometric mean of reference genes Cox7a2, Vps26a, and TATA-box-binding protein. Data are mean ± SD. **p ≤ .01; ***p ≤ .001; ****p ≤ .0001. Y-axes represent arbitrary units for normalized mRNA amounts. N = 8–10 rats per group.
Figure 3. Validation of interferon gamma (A) and (B) epithelial to mesenchymal transition pathways in the rat kidney. mRNA amounts of the selected genes were quantified by real-time quantitative polymerase chain reaction in the kidneys from 6-month-old rats treated with vehicle and 24-month-old rats treated with vehicle or RAD001. mRNA amounts of the genes of interest were normalized to a geometric mean of reference genes Cox7a2, Vps26a, and TATA-box-binding protein. Data are mean ± SD. **p ≤ .01; ***p ≤ .001; ****p ≤ .0001. Y-axes represent arbitrary units for normalized mRNA amounts. N = 8–10 rats per group.CC BY-NC-ND · PubMed Central
Figure 4. Representative photomicrographs illustrating longitudinal sections of hematoxylin and eosin (H&E)-stained kidneys (cortex region) from a 6-month-old rat treated with vehicle (A), a 24-month-old rat treated with vehicle (B) and a 24-month-old rat treated with RAD001 (C). Asterisks (*) in panel B indicate dilated renal tubules in the kidney from a 24-month-old rat treated with vehicle. Scale bars, 100 μm. (D) Graphical summary of semiquantitative histopathology scores. Data are mean ± SD. ****p ≤ .0001, **p≤ = .01. N = 8–10 rats per group.
Figure 4. Representative photomicrographs illustrating longitudinal sections of hematoxylin and eosin (H&E)-stained kidneys (cortex region) from a 6-month-old rat treated with vehicle (A), a 24-month-old rat treated with vehicle (B) and a 24-month-old rat treated with RAD001 (C). Asterisks (*) in panel B indicate dilated renal tubules in the kidney from a 24-month-old rat treated with vehicle. Scale bars, 100 μm. (D) Graphical summary of semiquantitative histopathology scores. Data are mean ± SD. ****p ≤ .0001, **p≤ = .01. N = 8–10 rats per group.CC BY-NC-ND · PubMed Central
Figure 5. (A) Validation of Myc target genes in the rat kidney. mRNA amounts of selected genes were quantified by real-time quantitative polymerase chain reaction in the kidneys from 6-month-old rats treated with vehicle and 24-month-old rats treated with vehicle or RAD001. mRNA amounts of genes of interest were normalized to a geometric mean of reference genes Cox7a2, Vps26a, and TATA-box-binding protein. Data are mean ± SD. **p ≤ .01; ***p ≤ .001; ****p ≤ .0001. Y-axes represent arbitrary units for normalized mRNA amounts. N = 8–10 rats per group. (B) c-Myc protein detected by immunoblotting in the spleen from 24-month-old rats treated with either vehicle alone or with RAD001. For the spleen protein samples, HPRT1 was used as a loading control. Densitometric quantification of c-Myc protein bands relative to HPRT1 (used as a loading control) is shown on the right hand side (B). *p ≤ .05, data are mean ± SD. N = 8–10 rats per group. (C) HEK293 cells were treated with vehicle (DMSO) as a negative control, or with increasing concentrations of RAD001 (1 nM, 5 nM, and 20 nM) for 24 hours and c-Myc protein was detected by immunoblotting (panel 1). (D) c-Myc protein amounts detected in HEK293 cells 6 hours following treatment with RAD001 (5 nM), Emetine (10 μM), and MG132 (10 μM) (panel 1 in D). In cases where either of these compounds was omitted, cells were treated with blank carriers: DMSO for RAD001 and MG132 and water for Emetine. Immunoblotting for p-S6K1(T389) and t-S6K1 was performed to demonstrate inhibition of the mTORC1 pathway by RAD001 (panels 2 and 3 in C and D). GAPDH is shown as a protein loading control (panel 4 in C and D).
Figure 5. (A) Validation of Myc target genes in the rat kidney. mRNA amounts of selected genes were quantified by real-time quantitative polymerase chain reaction in the kidneys from 6-month-old rats treated with vehicle and 24-month-old rats treated with vehicle or RAD001. mRNA amounts of genes of interest were normalized to a geometric mean of reference genes Cox7a2, Vps26a, and TATA-box-binding protein. Data are mean ± SD. **p ≤ .01; ***p ≤ .001; ****p ≤ .0001. Y-axes represent arbitrary units for normalized mRNA amounts. N = 8–10 rats per group. (B) c-Myc protein detected by immunoblotting in the spleen from 24-month-old rats treated with either vehicle alone or with RAD001. For the spleen protein samples, HPRT1 was used as a loading control. Densitometric quantification of c-Myc protein bands relative to HPRT1 (used as a loading control) is shown on the right hand side (B). *p ≤ .05, data are mean ± SD. N = 8–10 rats per group. (C) HEK293 cells were treated with vehicle (DMSO) as a negative control, or with increasing concentrations of RAD001 (1 nM, 5 nM, and 20 nM) for 24 hours and c-Myc protein was detected by immunoblotting (panel 1). (D) c-Myc protein amounts detected in HEK293 cells 6 hours following treatment with RAD001 (5 nM), Emetine (10 μM), and MG132 (10 μM) (panel 1 in D). In cases where either of these compounds was omitted, cells were treated with blank carriers: DMSO for RAD001 and MG132 and water for Emetine. Immunoblotting for p-S6K1(T389) and t-S6K1 was performed to demonstrate inhibition of the mTORC1 pathway by RAD001 (panels 2 and 3 in C and D). GAPDH is shown as a protein loading control (panel 4 in C and D).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 59

Metadata

Authors
Shavlakadze, T., Zhu, J., Wang, S., Zhou, W., Morin, B., Egerman, M. A., Fan, L., Wang, Y., Iartchouk, O., Meyer, A., Valdez, R. A., Mannick, J. B., Klickstein, L. B., & Glass, D. J.
Affiliations
  • Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
  • Genomics Institute of the Novartis Research Foundation (US)
  • Novartis Institutes for BioMedical Research (CH)
Corresponding author
Glass, David J
Venue
The Journals of Gerontology: Series A
Published
2018-01-03
Volume
73
Issue
7
Pages
845-852
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W2782332875
Cited by
59
References
33
Citations by year
2026: 5 · 2025: 6 · 2024: 1 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 9 · 2018: 6
FWCI
3.46
Type
journal article
Language
en
Open access
Locations
  • The Journals of Gerontology Series A (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Novartis
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
mTORC1 inhibition, rapalogs, everolimus, aging, chronic progressive nephropathy, c-Myc, gene expression changes, proteasome inhibition, liver, skeletal muscle
MeSH terms
Everolimus, Mechanistic Target of Rapamycin Complex 1, Aging, Animals, Drug Administration Schedule, Enzyme Inhibitors, Humans, Kidney, Liver, Longevity, Male, Gene Expression, Rats, Sprague-Dawley, Muscle, Skeletal, Gene Expression Profiling, Rats, Renal Insufficiency, Chronic, HEK293 Cells, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.